Advanced search
Publication Cover
Cancer Investigation Volume 35, 2017 - Issue 1
Submit an article Journal homepage
172
Views
10
CrossRef citations to date
0
Altmetric
Articles

The High Frequency of PIK3CA Mutations in Iranian Breast Cancer Patients

Ghasem Azizi TabeshMedical Genetics Department, Medical School, Tehran University of Medical Sciences, Tehran, Iran
,
Pantea IzadiMedical Genetics Department, Medical School, Tehran University of Medical Sciences, Tehran, IranCorrespondence[email protected]
,
Forouzandeh FereidooniIran National Tumor Bank, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
,
Amir Nader Emami RazaviIran National Tumor Bank, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
&
Javad Tavakkoly BazzazMedical Genetics Department, Medical School, Tehran University of Medical Sciences, Tehran, Iran
Pages 36-42 | Received 27 Feb 2016, Accepted 08 Oct 2016, Published online: 30 Nov 2016

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Haibo Wu, Wei Wang, Jun Du, Hong Li, Huogang Wang, Liangliang Huang, Hang Xiang, Jing Xie, Xiaoli Liu, Heng Li & Wenchu Lin. (2019) The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China. Cancer Management and Research 11, pages 1473-1492.
Read now

Articles from other publishers (9)

Jessica W. Chen, Karthikeyan Murugesan, Justin Y. Newberg, Ethan S. Sokol, Heidi M. Savage, Thomas J. Stout, Sophia L. Maund & Katherine E. Hutchinson. (2022) Comparison of PIK3CA Mutation Prevalence in Breast Cancer Across Predicted Ancestry Populations . JCO Precision Oncology:6.
Crossref
Ying-Zi Li, Bo Chen, Xiao-Yi Lin, Guo-Chun Zhang, Jian-Guo Lai, Cheukfai Li, Jia-Li Lin, Li-Ping Guo, Wei-Kai Xiao, Hsiaopei Mok, Chong-Yang Ren, Ling-Zhu Wen, Fang-Rong Cao, Xin Lin, Xiao-Fang Qi, Yang Liu & Ning Liao. (2022) Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern. Frontiers in Oncology 12.
Crossref
Minghan Jia, Ning Liao, Bo Chen, Guochun Zhang, Yulei Wang, Xuerui Li, Li Cao, Hsiaopei Mok, Chongyang Ren, Kai Li, Cheukfai Li, Lingzhu Wen, Jiali Lin, Guangnan Wei & Charles M. Balch. (2021) PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing. Breast Cancer 28:3, pages 644-652.
Crossref
Munmee Dutta, Hidewaki Nakagawa, Hiroaki Kato, Kazuhiro Maejima, Shota Sasagawa, Kaoru Nakano, Aya Sasaki-Oku, Akihiro Fujimoto, Raúl Nicolás Mateos, Ashwini Patil, Hiroko Tanaka, Satoru Miyano, Takushi Yasuda, Kenta Nakai & Masashi Fujita. (2020) Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma. PeerJ 8, pages e9294.
Crossref
Meysam Moghbeli. (2019) Genetic and molecular biology of breast cancer among Iranian patients. Journal of Translational Medicine 17:1.
Crossref
Gao Chanchan, Su Xiangyu, Shi Fangfang, Chen Yan & Gu Xiaoyi. (2018) The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials. PLOS ONE 13:9, pages e0204202.
Crossref
Guoli Li, Xinwu Guo, Ming Chen, Lili Tang, Hui Jiang, Julia X. Day, Yueliang Xie, Limin Peng, Xunxun Xu, Jinliang Li, Shouman Wang, Zhi Xiao, Lizhong Dai & Jun Wang. (2018) Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients. PLOS ONE 13:9, pages e0203495.
Crossref
Zahra Fathi, Nicholas L. Syn, Jian-Guo Zhou & Raheleh Roudi. (2018) Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention. Journal of Human Genetics 63:7, pages 783-794.
Crossref
Jia Luo, Guocheng Pi, He Xiao, Yunfei Ye, Qing Li, Lianhua Zhao, Huan Huang, Hong Luo, Qin Zhang, Dong Wang & Ge Wang. (2017) Torin2 enhances the radiosensitivity of MCF‑7 breast cancer cells by downregulating the mTOR signaling pathway and ATM phosphorylation. Molecular Medicine Reports.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.